Showing results (1271-1280 of 1,655) with videos related to

Sort By:
Pageof 166
Healthcare (Amsterdam, Netherlands)|January 31, 2021
Early serious illness communication in hospitalized patients: A study of the implementation of the Speaking About Goals and Expectations (SAGE) programJoshua R Lakin, Catherine G Arnold, Hannah Z Catzen, et al.
American Heart Journal|July 12, 2011
Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialJeffrey S Berger, Deepak L Bhatt, P Gabriel Steg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 4, 2017
Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus ErythematosusSokha Nhek, Robert Clancy, Kristen A Lee, et al.
Neuro-Oncology|May 12, 2004
Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiformeDavid A Larson, Jeffrey M Suplica, Susan M Chang, et al.
Brain Research. Brain Research Protocols|September 27, 2005
Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imagingMichal T Krauze, Tracy R Mcknight, Yoji Yamashita, et al.
The British Journal of Dermatology|February 17, 1999
Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgarisC N Ellis, L E Millikan, E B Smith, et al.
Nanomedicine (London, England)|February 6, 2014
Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumorsCharles O Noble, Michal T Krauze, Daryl C Drummond, et al.
Journal of the American College of Cardiology|September 29, 2018
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID TrialIris Baumgartner, Lars Norgren, F Gerry R Fowkes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 7, 1998
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constantA M Spence, M Muzi, M M Graham, et al.
British Journal of Cancer|February 16, 2012
A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancerA A Chiappori, M T Schreeder, M M Moezi, et al.
Pageof 166